Video Series: Current Topics in the Treatment of Advanced PCa
Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.
Latest Prostate Cancer News
Risk of being admitted for non-cancer conditions is 38% higher in the year after a PCa diagnosis compared with a year before.
The advice is useful as clinicians wait for formal guidelines.
Ablating only the prostate lobe with the tumor resulted in satisfactory mid-term functional outcomes, researchers reported.
Differential effect of 2012 USPSTF recommendations for primary care providers, urologists.
Patient age and tumor risk may be more strongly associated with use of expectant management for veterans with low-risk prostate cancer.
Antibiotics selected based on results of pre-biopsy rectal swab cultures.
Combination angiogenesis inhibition can be safely administered with supportive measures in metastatic castration-resistant prostate cancer (mCRPC).
Combined radiotherapy remains controversial due to the increased potential for toxicities.
Any baldness is associated with a 56% higher risk of dying from the malignancy.
Rate of unnecessary screening was 15.7% in men 65 years and older.
Many men are unaware of erectile function recovery time and problems with ejaculation.
Modified technique improved stress urinary incontinence in nearly three-quarters of patients.
Prostate cancer is 1.4 times more likely to develop in those with a PSA level of 2.5 ng/mL or higher.
Enzalutamide reduced the risk of disease progression by 56% in mCRPC patients.
A newly developed profiling method may be helpful in the management of patients with high-risk prostate cancer.
Prostate Cancer Videos
Sign up for free e-Newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Twice-Weekly Dialysis May Preserve Residual Kidney Function
- Robotic Nephrectomy of Kidney Tumors With Thrombi Feasible
- How to Prevent Sexual Transmission of Zika Virus
- Parathyroidectomy Cuts Mortality Risk in Patients With Severe SHPT
- Prostate Cancer Diagnosis Ups Risk of Non-Cancer Hospitalizations